Alper Özkan

514 total citations
21 papers, 363 citations indexed

About

Alper Özkan is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Alper Özkan has authored 21 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Alper Özkan's work include Cardiac Valve Diseases and Treatments (5 papers), Cardiovascular Function and Risk Factors (3 papers) and Lung Cancer Research Studies (3 papers). Alper Özkan is often cited by papers focused on Cardiac Valve Diseases and Treatments (5 papers), Cardiovascular Function and Risk Factors (3 papers) and Lung Cancer Research Studies (3 papers). Alper Özkan collaborates with scholars based in Türkiye, United States and Serbia. Alper Özkan's co-authors include Samir Kapadia, Thomas H. Marwick, E. Murat Tuzcu, Rory Hachamovitch, Murat Tuzcu, Nurşen Keleş, İbrahi̇m Hali̇l Tanboğa, Cıhangır Kaymaz, Mehmet Mustafa Can and Kenan Sönmez and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and RSC Advances.

In The Last Decade

Alper Özkan

20 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alper Özkan Türkiye 10 229 124 113 80 59 21 363
Takenori Okada Japan 12 190 0.8× 131 1.1× 39 0.3× 91 1.1× 41 0.7× 29 383
Arthur Filusch Germany 11 296 1.3× 234 1.9× 46 0.4× 56 0.7× 41 0.7× 21 460
Marc Wichert Germany 8 160 0.7× 180 1.5× 165 1.5× 16 0.2× 51 0.9× 13 543
M. Parisi Italy 6 54 0.2× 91 0.7× 85 0.8× 49 0.6× 27 0.5× 14 310
Amnon Eitan Israel 8 203 0.9× 154 1.2× 58 0.5× 32 0.4× 63 1.1× 24 362
Hongliang Yuan China 7 215 0.9× 114 0.9× 41 0.4× 34 0.4× 214 3.6× 10 598
Yangyang Qu China 9 127 0.6× 37 0.3× 35 0.3× 62 0.8× 101 1.7× 31 297
Felix Hofer Austria 9 165 0.7× 43 0.3× 84 0.7× 31 0.4× 59 1.0× 39 347
Alexey Dashkevich Germany 9 149 0.7× 107 0.9× 64 0.6× 35 0.4× 38 0.6× 33 305
Flavio Zuccarino Spain 9 54 0.2× 94 0.8× 22 0.2× 41 0.5× 27 0.5× 40 258

Countries citing papers authored by Alper Özkan

Since Specialization
Citations

This map shows the geographic impact of Alper Özkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alper Özkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alper Özkan more than expected).

Fields of papers citing papers by Alper Özkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alper Özkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alper Özkan. The network helps show where Alper Özkan may publish in the future.

Co-authorship network of co-authors of Alper Özkan

This figure shows the co-authorship network connecting the top 25 collaborators of Alper Özkan. A scholar is included among the top collaborators of Alper Özkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alper Özkan. Alper Özkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Özkan, Alper, et al.. (2020). Is there any correlation between HPV and early radioresponse before brachytherapy in cervix uteri carcinoma?. La radiologia medica. 125(10). 981–989. 1 indexed citations
3.
Kaymaz, Cıhangır, Nurşen Keleş, İbrahi̇m Hali̇l Tanboğa, et al.. (2014). The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI. The Anatolian Journal of Cardiology. 15(11). 899–906. 10 indexed citations
4.
Mayadağlı, Alpaslan, et al.. (2014). Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.. PubMed. 19(1). 157–63. 2 indexed citations
5.
Kapadia, Samir, Lars G. Svensson, Eric E. Roselli, et al.. (2014). Single center TAVR experience with a focus on the prevention and management of catastrophic complications. Catheterization and Cardiovascular Interventions. 84(5). 834–842. 18 indexed citations
6.
Özkan, Alper, Rory Hachamovitch, Samir Kapadia, E. Murat Tuzcu, & Thomas H. Marwick. (2013). Impact of Aortic Valve Replacement on Outcome of Symptomatic Patients With Severe Aortic Stenosis With Low Gradient and Preserved Left Ventricular Ejection Fraction. Circulation. 128(6). 622–631. 91 indexed citations
7.
Tanboğa, İbrahi̇m Hali̇l, et al.. (2013). Relationship between human platelet antigen-1 gene polymorphism and clopidogrel resistance in patients with coronary artery disease. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 41(5). 379–385. 4 indexed citations
8.
Ustaalıoğlu, Bala Başak Öven, Ahmet Bılıcı, Asuman Orçun, et al.. (2012). Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls. Clinical & Translational Oncology. 14(5). 356–361. 17 indexed citations
9.
Özkan, Alper, et al.. (2012). Giant Left Atrium. Journal of the American College of Cardiology. 60(8). e13–e13. 3 indexed citations
10.
Özkan, Alper. (2012). Low gradient "severe" aortic stenosis with preserved left ventricular ejection fraction.. PubMed. 2(1). 19–27. 14 indexed citations
11.
Shishehbor, Mehdi H., et al.. (2012). Outcomes of carotid stenting in patients with previous neck radiation. Catheterization and Cardiovascular Interventions. 82(5). 689–695. 7 indexed citations
12.
Tanboğa, İbrahi̇m Hali̇l, et al.. (2011). Neutrophil gelatinase-associated lipocalin levels in right and left heart failure: an observational study. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 11(6). 498–503. 5 indexed citations
13.
Özkan, Alper, Samir Kapadia, Murat Tuzcu, & Thomas H. Marwick. (2011). Assessment of left ventricular function in aortic stenosis. Nature Reviews Cardiology. 8(9). 494–501. 46 indexed citations
14.
Can, Mehmet Mustafa, İbrahi̇m Hali̇l Tanboğa, Alper Özkan, et al.. (2010). Enhanced hemostatic indices in patients with pulmonary arterial hypertension: An observational study. Thrombosis Research. 126(4). 280–282. 33 indexed citations
15.
Can, Mehmet Mustafa, İbrahi̇m Hali̇l Tanboğa, Alper Özkan, et al.. (2010). Acute Kidney Infarction Secondary to Intracardiac Thrombus Embolization in a Patient with Ischemic Dilated Cardiomyopathy. Cardiology. 117(3). 219–221. 6 indexed citations
16.
Erkol, Ayhan, et al.. (2009). Double-orifice mitral valve associated with bicuspid aortic valve: a rare case of incomplete form of Shone's complex. European Heart Journal - Cardiovascular Imaging. 10(6). 801–803. 5 indexed citations
17.
Can, Mehmet Mustafa, İbrahi̇m Hali̇l Tanboğa, Can Yücel Karabay, et al.. (2009). The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: Comparision of the PFA-100, multiplate electrical impedance aggregometry and verify now assays. Thrombosis Research. 125(4). e132–e137. 26 indexed citations
18.
Özkan, Alper, Alpaslan Mayadağlı, Cem Parlak, et al.. (2009). Induction Chemotherapy and Chemoradiation Therapy for Inoperable Locally Advanced Non–Small-Cell Lung Cancer: A Single-Institution Review of Two Different Regimens. Clinical Lung Cancer. 10(2). 124–129. 9 indexed citations
19.
Kücür, Mine, et al.. (2008). Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urologic Oncology Seminars and Original Investigations. 26(1). 47–52. 44 indexed citations
20.
Yumuk, Perran Fulden, Nazım Serdar Turhal, Mahmut Gümüş, et al.. (2005). Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer. BMC Cancer. 5(1). 10–10. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takenori Okada Breakdown of academic impact, for papers by Arthur Filusch Breakdown of academic impact, for papers by Marc Wichert Breakdown of academic impact, for papers by M. Parisi Breakdown of academic impact, for papers by Amnon Eitan Breakdown of academic impact, for papers by Hongliang Yuan Breakdown of academic impact, for papers by Yangyang Qu Breakdown of academic impact, for papers by Felix Hofer Breakdown of academic impact, for papers by Alexey Dashkevich Breakdown of academic impact, for papers by Flavio Zuccarino
Rankless by CCL
2026